(Reuters) -Shares of British animal genetics firm Genus shot up nearly 29% on Thursday, after it reported a 38% rise in annual adjusted pretax profit and signed a revised agreement to speed up the formation its China joint venture.<\/p>\n
\n Genus first partnered with Beijing Capital Agribusiness Co. Ltd (BCA) in 2019 to jointly market pigs resistant to the Porcine Reproductive and Respiratory Syndrome (PRRS) virus in China<\/p>\n
\n Under the revised deal, BCA will acquire a 51% stake in Genus’s Pig Improvement Company (PIC) unit in China.<\/p>\n
\n In turn, PIC will take ownership of BCA’s Future Bio-Tech business, tasked with securing regulatory approval for the gene-edited pigs in the country.<\/p>\n
\n The company’s shares, which hit a more than two-and-a-half-year high earlier in the day, gained 12% to 2,800 pence as of 0823 GMT.<\/p>\n
\n The accelerated JV formation positions Genus to deepen its footprint in China, the world’s largest pork market, as U.S. exporters face mounting tariff pressures.<\/p>\n
\n Peel Hunt analysts said there is “lots to like” in Genus, citing its strong profit and strong cash position, and added that the company will benefit from the JV.<\/p>\n
\n Genus, which operates in over 24 countries, reported adjusted pretax profit rose to 74.3 million pounds ($100.37 million) for the twelve months ended June 30, a 38% rise on a constant currency basis, driven by PIC growth in North America and Asia.<\/p>\n
\n ($1 = 0.7402 pounds)<\/p>\n
\n (Reporting by Raechel Thankam Job in Bengaluru; Editing by Rashmi Aich and Janane Venkatraman)<\/p>\n","protected":false},"excerpt":{"rendered":"(Reuters) -Shares of British animal genetics firm Genus shot up nearly 29% on Thursday, after it reported a…\n","protected":false},"author":2,"featured_media":7350,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[267,2441,70,16,15],"class_list":{"0":"post-397120","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-markets","10":"tag-science","11":"tag-uk","12":"tag-united-kingdom"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/397120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=397120"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/397120\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/7350"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=397120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=397120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=397120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}